Thrombomodulin enhances the invasive activity of mouse mammary tumor cells

Journal of Biochemistry

Volumn 137, Issue 5, 2005, Pages 579-586

  Niimi, Shingo ^a   Harashima, Mizuho ^b   Takayama, Kazuko ^b   Hara, Mayumi ^b   Hyuga, Masashi ^a   Seki, Taiichiro ^b   Ariga, Toyohiko ^b   Kawanishi, Toru ^a   Hayakawa, Takao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Invasion; Thrombin; Thrombomodulin

Indexed keywords

ANTICOAGULANT AGENT; GELATINASE A; HIRUDIN; IODINE 125; PROCOAGULANT; THROMBIN; THROMBIN INHIBITOR; THROMBIN RECEPTOR; THROMBOMODULIN; UROKINASE;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; BINDING SITE; BREAST TUMOR; CANCER INVASION; CANCER PATIENT; CELL PROLIFERATION; CELL STIMULATION; CHEMOTAXIS; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; THROMBOCYTE ACTIVATION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTAXIS; HIRUDINS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; THROMBIN; THROMBOMODULIN;

EID: 21044433359     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvi070     Document Type: Article

References (73)

1. Esmon, C.T. and Owen, W.G. (1981) Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc. Natl Acad. Sci. USA 78, 2249-2252
2. Esmon, C.T. (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264, 4743-4746
3. Ishii, H. and Majerus, P.W. (1985) Thrombomodulin is present in human plasma and urine. J. Clin. Invest. 76, 2178-2181
4. Molinari, A., Giorgetti, C., Lansen, J., Vaghi, F., Orsini, G., Faioni, E.M., and Mannucci, P.M. (1992) Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator "in vitro" and in a perfused rabbit heart model. Thromb. Haemost. 67, 226-232
5. Bajzar, L., Morser, J., and Nesheim, M. (1996) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271, 16603-16608
6. Pekovich, S.R., Bock, P.E., and Hoover, R.L. (2001) Thrombin- thrombomodulin activation of protein C facilitates the activation of progelatinase A. FEBS Lett. 494, 129-132
7. Esmon, N.L., Carroll, R.C., and Esmon, C.T. (1986) Thrombomodulin blocks the ability of thrombin to activate platelets. J. Biol. Chem. 258, 12238-12242
8. Esmon, C.T., Esmon, N.L., and Harris, K.W. (1983) Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J. Biol. Chem. 257, 7944-7947
9. Parkinson, J.F., Bang, N.U., and Garcia, J.G. (1993) Recombinant human thrombomodulin attenuates human endothelial cell activation by human thrombin. Arterioscler. Thromb. 13, 1119-1123
10. Li, J., Garnette, C.S., Cahn, M., Claytor, R.B., Rohrer, M.J., Dobson, J.G. Jr., Gerlitz, B., and Cutler, B.S. (2000) Recombinant thrombomodulin inhibits arterial smooth muscle cell proliferation induced by thrombin. J. Vasc. Surg. 32, 804-813
11. Lafay, M., Laguna, R., Le Bonniec, B.F., Lasne, D., Aiach, M., and Rendu, F. (1998) Thrombomodulin modulates the mitogenic response to thrombin of human umbilical vein endothelial cells. Thromb. Haemost. 79, 848-852
12. Nierodzik, M.L., Plotkin, A., Kajumo, F., and Karpatkin, S. (1991) Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J. Clin. Invest. 87, 229-236
13. Nierodzik, M.L., Kajumo, F., and Karpatkin, S. (1992) Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res. 52, 3267-3272
14. Esumi, N., Fan, D., and Fidler, J.I. (1991) Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res. 51, 4549-4556
15. Wojtukiewicz, M.Z., Tang, D.G., Ben-Josef, E., Renaud, C., Walz, D.A., and Honn, K.V. (1995) Solid tumor cells express functional 'tethered ligand' thrombin receptor. Cancer Res. 55, 698-704
16. Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., and Bar-Shavit, R. (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nat. Med. 4, 909-914
17. Hernandez-Rodriguez, N.A., Correa, E., Contreras-Paredes, A., and Green, L. (1999) Evidence that thrombin present in lungs of patients with pulmonary metastasis may contribute to the development of the disease. Lung Cancer 26, 157-167
18. Henrikson, K.P., Salazar, S.L., Fenton, J.W. II., and Pentecost, B.T. (1999) Role of thrombin receptor in breast cancer invasiveness. Br. J. Cancer 79, 401-406
19. Ogawa, H., Yonezawa, S., Maruyama, I., Matsushita, Y., Tezuka, Y., Toyoyama, H., Yanagi, M., Matsumoto, H., Nishijima, H., Shimotakahara, T., Aikou, T., and Sato, E. (2000) Expression of thrombomodulin in squamous cell carcinoma of the lungs: its relationship to lymph node metastasis and prognosis of the patients. Cancer Lett. 149, 95-103
20. Takebayashi, Y., Yamada, K., Maruyama, I., Fujii, R., Akiyama, S., and Aikou, T. (1995) The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett. 92, 1-7
21. Ordonez, N.G. (1997) Value of thrombomodulin immunostaining in the diagnosis of transitional cell carcinoma: a comparative study with carcinoembryonic antigen. Histopathology 31, 517-524
22. Ordonez, N.G. (1998) Thrombomodulin expression in transitional cell carcinoma. Am. J. Clin. Pathol. 110, 385-390
23. Matsumoto, M., Natsugoe, S., Nakashima, S., Shimada, M., Nakano, S., Kusano, C., Baba, M., Takao, S., Matsushita, Y., and Aikou, T. (2000) Biological evaluation of undifferentiated carcinoma of the esophagus. Ann. Surg. Oncol. 7, 204-209
24. Suehiro, T., Shimada, M., Matsumata, T., Taketomi, A., Yamamoto, K., and Sugimachi, K. (1995) Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinoma. Hepatology 21, 1285-1290
25. Wilhelm, S., Schmitt, M., Parkinson, J., Kuhn, W., Graeff, H., and Wilhelm O.G. (1998) Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc. Int. J. Oncol. 13, 645-651
26. Lindahl, A.K., Boffa, M.C., and Abildgaard, U. (1993) Increased plasma thrombomodulin in cancer patients. Thromb. Haemost. 69, 112-114
27. Boffa, M.C., Lapeyrere, C., Berard, M., Lindahl, A.K., Flageul, B., Chemaly, P., Abildgaard, U., and Dubertret, L. (1994) Plasma thrombomodulin level in malignancy varies according to the tumor type. Nouv. Rev. Fr. Hematol. 36, S87-88
28. Salmaggi, A., Eoli, M., Frigerio, S., Ciusani, E., Silvani, A., and Boiardi, A. (1999) Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and plasma thrombomodulin levels in glioblastoma patients. Cancer Lett. 146, 169-172
29. Liotta, L.A. (1986) Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 46, 1-7
30. Terranova, V.P., Hujanen, E.S., and Martin, G.R. (1986) Basement membrane and the invasive activity of metastatic tumor cells. J. Natl Cancer Inst. 77, 311-316
31. Gomi, K., Zushi, M., Honda, G., Kawahara, S., Matsuzaki, O., Jr., Kanabayashi, T., Yamamoto, S., Maruyama, I., and Suzuki, K. (1990) Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood 75, 1396-1399
32. Niimi, S., Oshizawa, T., Naotsuka, M., Ohba, S., Yokozawa, A., Murata, T., and Hayakawa, T. (2002) Establishment of a standard assay method for human thrombomodulin and determination of the activity of the Japanese reference standard. Biologicals 30, 69-76
33. Kawabata, S., Miura, T., Morita, T., Kato, H., Fujikawa, K., Iwanaga, S., Takada, K., Kimura, T., and Sakakibara, S. (1988) Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin. Eur. J. Biochem. 172, 17-25
34. Deryugina, E.I., Luo, G.X., Reisfeld, R.A., Bourdon, M.A., and Strongin, A. (1997) Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res. 17, 3201-3210
35. 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89, 114-123
36. Haeuptle, M.T., Aubert, M.L., Djiane J., Kraehenbuhl, J.P. (1983) Binding sites for lactogenic and somatogenic hormones from rabbit mammary gland and liver. J. Biol. Chem. 258, 305-314
37. Matsushita, Y., Yoshiie, K., Imamura, Y., Ogawa, H., Imamura, H., Takao, S., Yonezawa, S., Aikou, T., Maruyama, I., and Sato, E. (1998) A subcloned human esophageal squamous cell carcinoma cell line with low thrombomodulin expression showed increased invasiveness compared with a high thrombomodulin-expressing clone-thrombomodulin as a possible candidate for an adhesion molecule of squamous cell carcinoma. Cancer Lett. 127, 195-201
38. Hosaka, Y., Higuchi, T., Tsumagari, M., and Ishii, H. (2000) Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Lett. 161, 231-240
39. Zhang, Y., Weiler-Guettler, H., Chen, J., Wilhelm, O., Deng, Y., Qiu, F., Nakagawa, K., Klevesath, M., Wilhelm, S., Bohrer, H., Nakagawa, M., Graeff, H., Martin, E., Stern, D.M., Rosenberg, R.D., Ziegler, R., and Nawroth, P.P. (1998) Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J. Clin. Invest. 101, 1301-1309
40. Maruyama, I. and Majerus, PW (1985) The turnover of thrombin- thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J. Biol. Chem. 260, 15432-15438
41. Hart, I.R., Goode, N.T., and Wilson, R.E. (1989) Molecular aspects of the metastatic cascade. Biochim. Biophys. Acta 989, 65-84
42. Wells, A. (2000) Tumor invasion: role of growth factor-induced cell motility. Adv. Cancer Res. 78, 31-101
43. Matrisian, L.M. (1990) Metalloproteinases and their inhibitors in matrix remodeling. Ternds Genet. 6, 121-125
44. Collier, I.E., Wilhelm, S.M., Eisen, A.Z., Marmer, B.L., Grant, G.A., Seltzer, J.L., Kronberger, A., He, C.S., Bauer, E.A., and Goldberg, G.I. (1988) H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263, 6579-6587
45. Wilhelm, S.M., Collier, I.E., Marmer, B.L., Eisen, A.Z., Grant, G.A., and Goldberg, G.I. (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264, 17213-17221
46. Fessler, L.I., Duncan, K.G., Fessler, J.H., Salo, T., and Tryggvason, K. (1984) Identification of the procollagen IV cleavage products produced by a specific tumor collagenase. J. Biol. Chem. 259, 9783-9789
47. Woessner, J.F. Jr. (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154
48. Senior, R.M., Griffin, G.L., Fliszar, C.J., Shapiro, S.D., Goldberg, G.I., and Welgus, H.G. (1991) Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266, 7870-7875
49. Murphy, G., Cockett, M.I., Ward, R.V., and Docherty, A.J. (1991) Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitive comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinae (PUMP). Biochem. J. 277, 277-279
50. Nguyen, Q., Murphy, G., Hughes, C.E., Mort, J.S., and Roughley, P.J. (1993) Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem. J. 295, 595-598
51. Fosang, A.J., Last, K., Knauper, V., Neame, P.J., Murphy, G., Hardingham, T.E., Tschesche, H., and Hamilton, J.A. (1993) Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem. J. 295, 273-276
52. Sires, U.I., Griffin, G.L., Broekelmann, T.J., Mecham, R.P., Murphy, G., Chung, A.E., Welgus, H.G., and Senior, R.M. (1993) Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J. Biol. Chem. 268, 2069-2074
53. Zucker, S., Conner, C., DiMassmo, B.I., Ende, H., Drews, M., Seiki, M., and Bahou, W.F. (1995) Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J. Biol. Chem. 270, 23730-23738
54. Galis, Z.S., Kranzhofer, R., Fenton, J.W. II., and Libby, P. (1997) Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17, 483-489
55. Nguyen, M., Arkell, J., and Jackson, C.J. (1999) Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase. Lab. Invest. 79, 467-475
56. Pekovich, S.R., Bock, P.E., and Hoover, R.L. (2001) Thrombin- thrombomodulin activation of protein C facilitates the activation of progelatinase A. FEBS Lett. 694, 129-132
57. Lafleur, M.A., Hollenberg, M.D., Atkinson, S.J., Knauper, V., Murphy, G., and Edwards, D.R. (2001) Activation of pro(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. Biochem. J. 357, 107-115
58. Maragoudakis, M.E., Kraniti, N., Giannopoulou, E., Alexopoulos, K., and Matsuokas, J. (2001) Modulation of angiogenesis and progelatinase A by thrombin receptor mimetics and antagonists. Endothelium 8, 195-205
59. Liu, Y., Gilcrease, M.Z., Henderson, Y., Yuan, X.H., Clayman, G.L., and Chen, Z. (2001) Expression of protease-activated receptor 1 in oral squamous cell carcinoma. Cancer Lett. 169, 173-180
60. Stetler-Stevenson, W.G., Aznavoorian, S., and Liotta, L.A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell. Biol. 9, 541-573
61. Himelstein, B.P., Canete-Soler, R., Bernhard, E.J., Dilks, D.W., and Muschel, R.J. (1994) Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis. 14, 246-258
62. Bernhard, E.J., Gruber, S.B., and Muschel, R.J. (1994) Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl Acad. Sci. USA 91, 4293-4297
63. MacDougall, J.R., and Matrisian, L.M. (1995) Contribution of tumor and stromal matrix metalloroteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14, 351-362
64. Hua, J. and Muschel, R.J. (1996) Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res. 56, 5279-5284
65. Kim, J., Yu, W., Kovalski, K., and Ossowski, L. (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94, 353-362
66. Hahn-Dantona, E., Ramos-DeSimone, N., Sipley, J., Nagase, H., French, D.L., and Quigley, J.P. (1999) Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases. Ann. N. Y. Acad. Sci. 878, 372-387
67. John, A. and Tuszynski, G. (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 7, 14-23
68. Giannelli, G. and Antonaci, S. (2002) Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications. Histol. Histopathol. 17, 339-345
69. Fernandez-Patron, C., Zhang, Y., Radomski, M.W., Hollenberg, M.D., and Davidge, S.T. (1999) Rapid release of matrix metalloproteinase (MMP)-2 by thrombin in the rat aorta: modulation by protein tyrosine kinase/phosphatase. Thromb. Haemost. 82, 1353-1357
70. Duhamel-Clérin, E., Orvain, C., Lanza, F., Cazenave, J.P., and Klein-Soyer, C. (1997) Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17, 1931-1938
71. Liu, W.H., Chen, X.M., and Fu, B. (2000) Thrombin stimulates MMP-9 mRNA expression through AP-1 pathway in human mesangial cells. Acta. Pharmacol. Sin. 21, 641-645
72. Yoshida, E., Verrusio, E.N., Mihara, H., Oh, D., and Kwaan, H.C. (1994) Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin. Cancer Res. 54, 3300-3304
73. Benezra, M., Vlodavsky, I., and Bar-Shavit, R. (1992) Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase. Exp. Cell Res. 201, 208-215